Use of apoptosis-specific eIF-5A siRNAs and antisense polynucleotides to inhibit/suppress an inflammatory response

Details for Australian Patent Application No. 2005269647 (hide)

Owner Senesco Technologies, Inc.

Inventors Thompson, John E.

Agent Shelston IP

Pub. Number AU-B-2005269647

PCT Pub. Number WO2006/014752

Priority 60/589,073 20.07.04 US

Filing date 20 July 2005

Wipo publication date 9 February 2006

Acceptance publication date 12 November 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/014752 Priority application(s): WO2006/014752

12 November 2009 Application Accepted

  Published as AU-B-2005269647

11 March 2010 Standard Patent Sealed

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005269658-Actuator casing

2005269646-Blood collection assembly